Liberty BioSecurity
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact
Access Octomono Masonry Settings

Media

Alzheimer’s one day may be predicted during eye exam

8/23/2018

 
Noninvasive test may screen for disease before symptoms appear

​B
y Jim Dryden

It may be possible in the future to screen patients for Alzheimer’s disease using an eye exam.

Using technology similar to what is found in many eye doctors’ offices, researchers at Washington University School of Medicine in St. Louis have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease.

Their study, involving 30 patients, is published Aug. 23 in the journal JAMA Ophthalmology.


Read More

    Categories

    All
    Interviews
    Press Releases
    Publications
    Videos
    White Papers

    Archives

    February 2021
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    April 2019
    November 2018
    October 2018
    August 2018
    May 2018
    April 2018
    March 2018

Home
Our Team
Sciences
Media
Careers

Contact​
Established in 2014, Liberty Biosecurity is a privately-owned entity that in 2016 became a proud founding member of the EdenRoc Sciences family of life sciences companies and investments. Liberty Biosecurity Pty Ltd (Australia) was founded in 2016 and is registered under ABN 42612486325
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact